.svg){kind=small}
Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
INDO Cannabis is stocked at 13 licensed dispensaries across Nevada, with the deepest coverage in Las Vegas, Ely, and Reno. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In October 2026, INDO Cannabis concentrated 81.33% of sales in Vapor Pens while Capsules accounted for 9.98% and Topical 8.30%, with Pre-Roll shrinking to 0.40%; within this mix, Vapor Pens declined -10.27% year over year and -15.68% month over month, while Capsules fell -57.94% YoY and -27.63% MoM. Despite an average price rising 16.84% YoY to $32.77, category-level revenue contracted, as Topical dropped -16.17% YoY and -17.83% MoM and Pre-Roll plunged -92.53% YoY and -38.05% MoM; the pattern implies the portfolio is over-weighted to a single category that is softening both YoY and MoM, magnifying downside when adjacent categories are also retreating.
With Vapor Pens at rank 9 in Nevada and holding four-fifths of brand sales, the -15.68% MoM slide in the lead category exerts more pressure than the -27.63% MoM drop in Capsules can offset, suggesting share defense hinges on stabilizing pen velocity rather than expanding smaller lines. The combination of a 16.84% YoY price lift alongside -10.27% YoY sales contraction in Vapor Pens, plus double-digit MoM declines across Capsules (-27.63%) and Topical (-17.83%), implies current pricing and assortment are skewed toward higher ticket but lower throughput products, so near-term positioning depends on rebalancing mix within Vapor Pens and reallocating attention away from the sub-0.50% Pre-Roll footprint that is down -92.53% YoY.
Competitive Landscape
INDO Cannabis sits at rank #9 in NV Vapor Pens in October 2026, a 2-place improvement from rank #11 in October 2025, but down 2 positions from its July 2026 peak at #7; this near-term slippage contrasts with a market where Rove held #1 while its sales fell 18.3% year over year and STIIIZY stayed at #2 with a 26.2% year-over-year decline, indicating that stability in rank can coexist with double-digit contractions, whereas Dime Industries surged from #24 to #3 on 593.9% year-over-year sales growth, compressing headroom above INDO Cannabis faster than the category’s leaders are giving it back; the pattern implies INDO Cannabis’s YoY rank climb is real but its slide from #7 to #9 over the last three months signals momentum loss precisely as a fast-rising mid-tier competitor tightens the ladder.
Notable Products
INDO Cannabis is leaning on very recent launches in October 2026, with 57 new products generating 72.2% of brand sales and several in the top lineup, including Frog Poison Distillate Disposable (2g). That tilt pairs with a price position 7.8% below similar products, so much of its revenue comes from newly launched, lower-priced vapor pens.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
